Improving the physician-patient cardiovascular risk dialogue to improve statin adherence

BMC Family Practice

Volumn 10, Issue , 2009, Pages

  Casebeer, Linda ^a   Huber, Craig ^b   Bennett, Nancy ^a   Shillman, Rachael ^a   Abdolrasulnia, Maziar ^a   Salinas, Gregory D ^a   Zhang, Sijian ^c  

^a Outcomes Inc   (United States)

^b ASTRAZENECA   (United Kingdom)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; DOCTOR PATIENT RELATION; EDUCATION PROGRAM; HEALTH PROGRAM; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT EDUCATION; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUNSELING; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR;

ADULT; AGED; ANALYSIS OF VARIANCE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASES; COUNSELING; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS; QUESTIONNAIRES; RISK FACTORS;

EID: 68149107754     PISSN: None     EISSN: 14712296     Source Type: Journal    
DOI: 10.1186/1471-2296-10-48     Document Type: Article

References (20)

1. Recognizing and improving patient nonadherence to statin therapy. HJ Chaudhry B McDermott, Curr Atheroscler Rep 2008 10 19 24 10.1007/s11883-008- 0004-4 18366981
2. How can adherence to lipid-lowering medication be improved? A systematic review of randomized controlled trials. A Schedlbauer K Schroeder T Fahey, Fam Pract 2007 24 380 387 10.1093/fampra/cmm030 17630270 (Pubitemid 47407530)
3. The long-term course of low-density lipoprotein cholesterol after initiation of statin treatment: retrospective database analysis over 3 years in health maintenance organization enrollees. H Caspard AK Chan AM Walker, Clin Ther 2005 27 1622 1628 10.1016/j.clinthera.2005.09.004 16330299 (Pubitemid 41739499)
4. Medication adherence trends with statins. MA Huser TS Evans V Berger, Adv Ther 2005 22 163 171 10.1007/BF02849887 16020406
5. Interventions to Enhance Patient Adherence to Medication Prescriptions. Scientific Review. HP McDonald AX Garg RB Haynes, JAMA 2002 288 2868 2879 10.1001/jama.288.22.2868 12472329 (Pubitemid 35425073)
6. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. CA Jackevicius M Mamdani JV Tu, JAMA 2002 288 462 467 10.1001/jama.288.4.462 12132976
7. Suboptimal statin adherence and discontinuation in primary and secondary prevention populations. JJ Ellis SR Erickson JG Stevenson SJ Bernstein RA Stiles AM Fendrick, J Gen Intern Med 2004 19 638 645 15209602 10.1111/j.1525-1497. 2004.30516.x (Pubitemid 38803154)
8. Enhancing Drug Compliance in Lipid-Lowering Treatment. JH La Rosa JC La Rosa, Arch Fam Med 2000 9 1169 1175 10.1001/archfami.9.10.1169 11115225
9. How do providers assess antihypertensive medication adherence in medical encounters? BG Bokhour DR Berlowitz JA Long NR Kressin, J Gen Intern Med 2006 21 577 583 16808739 10.1111/j.1525-1497.2006.00397.x (Pubitemid 43804819)
10. A critical dialogue: communicating with type 2 diabetes patients about cardiovascular risk. P Roach D Marrero, Vasc Health Risk Manag 2005 1 301 307 17315602 10.2147/vhrm.2005.1.4.301
11. Physician-patient communication about prescription medication nonadherence: a 50 state study of America's seniors. IB Wilson C Schoen P Neuman MK Stollo WH Rogers H Chang DG Safran, J Gen Intern Med 2007 22 6 12 17351835 10.1007/s11606-006-0093-0 (Pubitemid 47308785)
12. Beneath the surface: discovering the unvoiced concerns of older adults with type 2 diabetes mellitus. J Tija JL Givens JH Karlawish A Okoli-Umeweni FK Barg, Health Educ Res 2008 23 40 52 10.1093/her/cyl161 17272292
13. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial. JK Lee KA Grace AJ Taylor, JAMA 2006 296 2563 2571 10.1001/jama.296.21.joc60162 17101639 (Pubitemid 44903860)
14. How should effectiveness of risk communication to aid patients' decisions be judged? A review of the literature. A Edwards G Elwyn, Med Decis Making 1999 19 428 434 10.1177/0272989X9901900411 10520681 (Pubitemid 29474769)
15. Patient-based outcome results from a cluster randomized trial of shared decision making skill development and use of risk communication aids in general practice. A Edwards G Elwyn K Hood C Atwell M Robling H Houston P Kinnersley T Rusell Study Steering Group, Fam Pract 2004 21 347 354 10.1093/fampra/cmh402 15249521 (Pubitemid 39172054)
16. The transtheoretical model of health behavior change. JO Prochaska WF Velicer, Am J Health Promo 1997 12 38 48
17. Use of the transtheoretical model in the medication use process. DL Ficke KB Farris, Ann Pharmacother 2005 39 1325 1330 10.1345/aph.1G122 15956227 (Pubitemid 40943188)
18. What patients want from primary care consultations: a discrete choice experiment to identify patients' priorities. S Cheraghi-Sohi AR Hole N Mead R McDonald D Whalley P Bower M Roland, Ann Fam Med 2008 6 107 115 18332402 10.1370/afm.816
19. Patients' anxiety and expectations: how they influence family physicians' decisions to order cancer screening tests. J Haggerty F Tudiver JB Brown C Herbert A Ciampi R Guilbert, Can Fam Physician 2005 51 1658 1659 16926946
20. Shared decision-making in primary care: the neglected second half of the consultation. G Elwyn A Edwards P Kinnersley, Br J Gen Pract 1999 49 477 482 10562751